Sinergium Biotech is an Argentine biopharmaceutical company specializing in the research, development, production and marketing of high complexity vaccines and biopharmaceuticals.
SiNERGIUM Biotech's unique characteristics worldwide, it carries out an innovative productive model of strategic alliances with national and international laboratories that allows: the transfer and availability of state-of-the-art technologies.
SINERGIUM Biotech was founded in 2011. The company is headquartered in Garin, Buenos Aires, Argentina.
SINERGIUM Biotech implements and develops new approaches and techniques to generate solutions that add value. The company encourages teams and peers in the development of new concepts, methods and approaches towards continuous improvement and professional ethics.
Sinergium Biotech owns a 20,000 sqm production facility located in Garin, Buenos Aires, Argentina, with state-of-the-art technology aligned with the highest quality standards. Sinergium Biotech is currently manufacturing more than 13 million doses of different vaccines, including for seasonal influenza, pneumococcal and HPV.